Literature DB >> 18725423

Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Chengming Wang1, Frederik W van Ginkel, Teayoun Kim, Dan Li, Yihang Li, John C Dennis, Bernhard Kaltenboeck.   

Abstract

Severe chlamydial disease typically occurs after previous infections and results from a hypersensitivity response that is also required for chlamydial elimination. Here, we quantitatively dissected the immune and disease responses to repeated Chlamydia pneumoniae lung infection by multivariate modeling with four dichotomous effects: mouse strain (A/J or C57BL/6), dietary protein content (14% protein and 0.3% L-cysteine-0.9% L-arginine, or 24% protein and 0.5% L-cysteine-2.0% L-arginine), dietary antioxidant content (90 IU alpha-tocopherol/kg body weight versus 450 IU alpha-tocopherol/kg and 0.1% g L-ascorbate), and time course (3 or 10 days postinfection). Following intranasal C. pneumoniae challenge, C57BL/6 mice on a low-protein/low-antioxidant diet, but not C57BL/6 mice on other diets or A/J mice, exhibited profoundly suppressed early lung inflammatory and pan-T-cell (CD3delta(+)) and helper T-cell (CD45) responses on day 3 but later strongly exacerbated disease on day 10. Contrast analyses characterized severe C. pneumoniae disease as being a delayed-type hypersensitivity (DTH) response with increased lung macrophage and Th1 cell marker transcripts, increased Th1:Th2 ratios, and Th1 cytokine-driven inflammation. Results from functional analyses by DTH, enzyme-linked immunospot, and immunohistofluorescence assays were consistent with the results obtained by transcript analysis. Thus, chlamydial disease after secondary infection is a temporal dysregulation of the T-cell response characterized by a profoundly delayed T-helper cell response that results in a failure to eliminate the pathogen and provokes later pathological Th1 inflammation. This delayed T-cell response is under host genetic control and nutritional influence. The mechanism that temporally and quantitatively regulates the host T-cell population is the critical determinant in chlamydial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725423      PMCID: PMC2573349          DOI: 10.1128/IAI.00569-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

1.  Therapeutic Chlamydophila abortus and C. pecorum vaccination transiently reduces bovine mastitis associated with Chlamydophila infection.

Authors:  Carolin Biesenkamp-Uhe; Yihang Li; Hans-Robert Hehnen; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

2.  Rapid high-yield mRNA extraction for reverse-transcription PCR.

Authors:  Chengming Wang; Teayoun Kim; Dongya Gao; Alexander Vaglenov; Bernhard Kaltenboeck
Journal:  J Biochem Biophys Methods       Date:  2006-11-07

Review 3.  Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Trends Microbiol       Date:  1994-03       Impact factor: 17.079

4.  Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice.

Authors:  Z P Yang; P K Cummings; D L Patton; C C Kuo
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

Review 5.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.

Authors:  H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 8.  The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes.

Authors:  Emily J Swindle; Dean D Metcalfe
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

9.  Role of H-2 and non-H-2-related genes in mouse susceptibility to Chlamydia psittaci.

Authors:  D Buzoni-Gatel; F Bernard; M Pla; A Rodolakis; F Lantier
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.738

10.  Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians.

Authors:  A Natividad; N Hanchard; M J Holland; O S M Mahdi; M Diakite; K Rockett; O Jallow; H M Joof; D P Kwiatkowski; D C W Mabey; R L Bailey
Journal:  Genes Immun       Date:  2007-03-01       Impact factor: 2.676

View more
  3 in total

1.  Defining species-specific immunodominant B cell epitopes for molecular serology of Chlamydia species.

Authors:  K Shamsur Rahman; Erfan U Chowdhury; Anil Poudel; Anke Ruettger; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

2.  Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Authors:  Kelly L Asquith; Jay C Horvat; Gerard E Kaiko; Alison J Carey; Kenneth W Beagley; Philip M Hansbro; Paul S Foster
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

3.  TLR3 Deficiency Leads to a Dysregulation in the Global Gene-Expression Profile in Murine Oviduct Epithelial Cells Infected with Chlamydia muridarum.

Authors:  Ramesh Kumar; Wilbert A Derbigny
Journal:  Int J Microbiol Curr Res       Date:  2018-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.